Skip to content

13F-HR filed by VHCP Management III, LLC

VHCP Management III, LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-13, with 17 holding rows worth $214,180,000.

Accession
0000950123-19-007812
Filed
2019-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2019

A holdings report, 17 entries on the cover page, a total value of $214,180,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $214,180,000 with VALUE read as thousands by filing date, 13F file number 028-18930. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Milestone Pharmaceuticals Inc59935V107COM2,066,529$56,106,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock1,611,329$41,492,000thousands by filing date
RA PHARMACEUTICALS INC74933V108COM670,350$20,157,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM637,884$14,129,000thousands by filing date
ObsEva SAH5861P103COM1,159,789$13,117,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM1,072,348$12,986,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 21,251,898$11,580,000thousands by filing date
TRICIDA INC89610F101COM289,746$11,433,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock2,708,207$10,264,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR676,252$9,461,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM1,258,964$5,225,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A312,320$4,229,000thousands by filing date
BELLEROPHON THERAPEUTICS INC078771102COM2,417,227$1,450,000thousands by filing date
KADMON HLDGS INC48283N106COM422,141$870,000thousands by filing date
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock66,667$819,000thousands by filing date
GEMPHIRE THERAPEUTICS INC36870A108COM798,066$646,000thousands by filing date
PROTEOSTASIS THERAPEUTICS IN74373B109COM221,267$216,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-19-007812this filing2019-08-13acceptance time not in the bulk data set